⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PPBT News
Purple Biotech Ltd. American Depositary Shares
Purple Biotech Announces Plan to Implement ADS Ratio Change
globenewswire.com
PPBT
Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240
globenewswire.com
PPBT
Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025
globenewswire.com
PPBT
Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress
globenewswire.com
PPBT
Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform
globenewswire.com
PPBT